| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
Accelerated hyperfractionated thoracic radiation therapy (AHTRT) plus concomitant VP16-CDDP chemotherapy for unresectable stage III non-small cell lung cancer (NSCLC)
|
|
|
1994
|
10 |
S1 |
p. S336-
1 p.
|
article
|
| 2 |
A comparison of methods for Phase II cancer clinical trials: advantages of the triangular test, a group sequential method
|
Bellissant, Eric
|
|
1994
|
10 |
S1 |
p. S105-S115
11 p.
|
article
|
| 3 |
Alternating radiotherapy and chemotherapy in limited small cell lung cancer: the IGR protocols
|
Arriagada, R.
|
|
1994
|
10 |
S1 |
p. S289-S298
10 p.
|
article
|
| 4 |
A phase III randomized study of concurrent radical accelerated radiotherapy (RT) and carboplatin in inoperable non-small cell lung cancer (NSCLC)
|
|
|
1994
|
10 |
S1 |
p. S335-
1 p.
|
article
|
| 5 |
A phase II study of vindesine and cisplatin (VP) used concurrently with thoracic radiotherapy (TRT) for locally advanced non-small cell lung cancer (NSCLC)
|
|
|
1994
|
10 |
S1 |
p. S336-
1 p.
|
article
|
| 6 |
Biological basis of combined therapy
|
Souhami, R.L.
|
|
1994
|
10 |
S1 |
p. S3-S5
3 p.
|
article
|
| 7 |
Biology of lung cancer
|
Stahel, Rolf A.
|
|
1994
|
10 |
S1 |
p. S59-S65
7 p.
|
article
|
| 8 |
Challenges of preoperative chemotherapy in non-small cell lung cancer
|
Johnson, David H.
|
|
1994
|
10 |
S1 |
p. S195-S203
9 p.
|
article
|
| 9 |
Characterization of camptothecin analog (CPT-11) resistant human lung cancer cells and its resistance mechanism
|
|
|
1994
|
10 |
S1 |
p. S332-S333
2 p.
|
article
|
| 10 |
Chemotherapy dose intensity in small cell lung cancer
|
Souhami, R.L.
|
|
1994
|
10 |
S1 |
p. S175-S185
11 p.
|
article
|
| 11 |
Chemotherapy preceding surgery and radiotherapy in non-small cell lung cancer (NSCLC) patients with biopsy-proven N2 disease: a phase II EORTC study
|
|
|
1994
|
10 |
S1 |
p. S334-
1 p.
|
article
|
| 12 |
Combined modality therapy in small cell lung cancer
|
Bunn, P.
|
|
1994
|
10 |
S1 |
p. S25-S28
4 p.
|
article
|
| 13 |
Combined modality treatment for locally advanced non-small cell lung cancer — which control arm?
|
Johnson, David H.
|
|
1994
|
10 |
S1 |
p. S231-S238
8 p.
|
article
|
| 14 |
Combined radiation and chemotherapy for unresectable non-small cell lung carcinoma
|
Bleehen, N.M.
|
|
1994
|
10 |
S1 |
p. S19-S23
5 p.
|
article
|
| 15 |
Comparison of treatment results between interdigitating and simultaneous chemotherapy and radiotherapy for limited small cell lung cancer
|
|
|
1994
|
10 |
S1 |
p. S339-
1 p.
|
article
|
| 16 |
Complications associated with the treatment of small cell lung cancer
|
Feld, Ronald
|
|
1994
|
10 |
S1 |
p. S307-S317
11 p.
|
article
|
| 17 |
Concomitant chemoradiotherapy for non-small cell lung cancer
|
Vokes, Everett E.
|
|
1994
|
10 |
S1 |
p. S253-S261
9 p.
|
article
|
| 18 |
Concurrent approaches to combined chemotherapy and chest radiotherapy for the treatment of patients with limited stage small cell lung cancer
|
Johnson, Bruce E.
|
|
1994
|
10 |
S1 |
p. S281-S287
7 p.
|
article
|
| 19 |
Concurrent carboplatin (CBDCA) and radiotherapy (RT) for unresectable stage III (Mo) non-small cell lung cancer (NSCLC)
|
|
|
1994
|
10 |
S1 |
p. S335-S336
2 p.
|
article
|
| 20 |
Concurrent platinum (CDDP)-etoposide (VP-16) chemotherapy plus thoracic radiotherapy (TRT) for limited stage small cell lung cancer (SCLC)
|
|
|
1994
|
10 |
S1 |
p. S337-
1 p.
|
article
|
| 21 |
Considerations on radiotherapy dose intensity for limited small cell lung cancer
|
Turrisi, Andrew T.
|
|
1994
|
10 |
S1 |
p. S167-S173
7 p.
|
article
|
| 22 |
Delayed chest irradiation for patients with limited stage (LS) small cell lung cancer (SCLC)
|
|
|
1994
|
10 |
S1 |
p. S338-S339
2 p.
|
article
|
| 23 |
Does adjuvant chemotherapy decrease distant metastasis formation in patients with non-small cell lung cancer?
|
Green, Mark R.
|
|
1994
|
10 |
S1 |
p. S187-S194
8 p.
|
article
|
| 24 |
Dose intensity in lung cancer treatment
|
Cox, J.
|
|
1994
|
10 |
S1 |
p. S11-S13
3 p.
|
article
|
| 25 |
Dose intensity of radiation therapy in non-small cell carcinoma of the lung: a review of RTOG data and strategies
|
Cox, James D.
|
|
1994
|
10 |
S1 |
p. S161-S166
6 p.
|
article
|
| 26 |
Early stopping rules and long-term follow-up in Phase III trials
|
Pignon, Jean-Pierre
|
|
1994
|
10 |
S1 |
p. S151-S159
9 p.
|
article
|
| 27 |
Effects of All-Trans Retinoic (TRA) on small cell lung cancer (SCLC)
|
|
|
1994
|
10 |
S1 |
p. S331-S332
2 p.
|
article
|
| 28 |
Factors confounding evaluation of treatment effect in lung cancer
|
Østerlind, Kell
|
|
1994
|
10 |
S1 |
p. S97-S103
7 p.
|
article
|
| 29 |
Factors influencing use of alternating chemotherapy and radiation schedules in small cell lung cancer
|
Gregor, Anna
|
|
1994
|
10 |
S1 |
p. S299-S305
7 p.
|
article
|
| 30 |
Fractionation and dose in thoracic radiotherapy
|
Saunders, M.I.
|
|
1994
|
10 |
S1 |
p. S245-S252
8 p.
|
article
|
| 31 |
Fundamental bases of combined therapy in lung cancer: cell resistance to chemotherapy and radiotherapy
|
Duchesne, Gillian M.
|
|
1994
|
10 |
S1 |
p. S67-S72
6 p.
|
article
|
| 32 |
Infusion cisplatin based chemotherapy plus accelerated hyperfractionated thoracic radiation therapy for limited small cell carcinoma of the lung
|
|
|
1994
|
10 |
S1 |
p. S339-S340
2 p.
|
article
|
| 33 |
Integrated clinical and basic studies related to circumventing non-small cell lung cancer drug resistance
|
Mulshine, James L.
|
|
1994
|
10 |
S1 |
p. S73-S81
9 p.
|
article
|
| 34 |
Introduction
|
|
|
1994
|
10 |
S1 |
p. S1-
1 p.
|
article
|
| 35 |
Investigations with PET-scan, Octreoscan and in vitro-assay of sensitivity to cytotoxic drugs in SCLC. A preliminary report
|
|
|
1994
|
10 |
S1 |
p. S331-
1 p.
|
article
|
| 36 |
Is preoperative or postoperative radiation therapy indicated in non-small cell cancer of the lung?
|
Payne, David G.
|
|
1994
|
10 |
S1 |
p. S205-S212
8 p.
|
article
|
| 37 |
Meta-analyses of randomized clinical trials: how to improve their quality?
|
Pignon, Jean-Pierre
|
|
1994
|
10 |
S1 |
p. S135-S141
7 p.
|
article
|
| 38 |
Modelling the consequences of delay in the timing of thoracic irradiation (TI) in the combined modality treatment of limited stage small cell lung cancer (LSCLC)
|
|
|
1994
|
10 |
S1 |
p. S337-S338
2 p.
|
article
|
| 39 |
Modelling the process of drug resistance
|
Goldie, James H.
|
|
1994
|
10 |
S1 |
p. S91-S96
6 p.
|
article
|
| 40 |
New perspectives in combined radiotherapy and chemotherapy treatment
|
Tannock, Ian F.
|
|
1994
|
10 |
S1 |
p. S29-S51
23 p.
|
article
|
| 41 |
Normal lung biology
|
Mattson, Karin
|
|
1994
|
10 |
S1 |
p. S53-S58
6 p.
|
article
|
| 42 |
Phase III studies in the therapy of small cell lung cancer (SCLC) : a North Central Cancer Treatment Group (NCCTG) trial
|
|
|
1994
|
10 |
S1 |
p. S338-
1 p.
|
article
|
| 43 |
Pitfalls and biases in the reporting and interpretation of the results of clinical trials
|
Parmar, Mahesh K.B.
|
|
1994
|
10 |
S1 |
p. S143-S150
8 p.
|
article
|
| 44 |
Predictive testing of radiosensitivity in non-small cell carcinoma of the lung
|
Saunders, M.I.
|
|
1994
|
10 |
S1 |
p. S83-S90
8 p.
|
article
|
| 45 |
Pre-operative and post-operative treatments in Stage III NSCLC
|
Green, M.
|
|
1994
|
10 |
S1 |
p. S15-S17
3 p.
|
article
|
| 46 |
Radiation sensitivities in various anticancer drug resistant human lung cancer cell lines and mechanism of radioresistance in cis-Diamminedichloroplatinum (II) resistant lung cancer cell line
|
|
|
1994
|
10 |
S1 |
p. S333-
1 p.
|
article
|
| 47 |
Radiosensitization by cytotoxic drugs. The EORTC experience by the Radiotherapy and Lung Cancer Cooperative Groups
|
Schaake-Koning, C.
|
|
1994
|
10 |
S1 |
p. S263-S270
8 p.
|
article
|
| 48 |
Radiotherapy alone versus combined chemotherapy and radiotherapy in unresectable non-small cell lung carcinoma
|
Le Chevalier, Thierry
|
|
1994
|
10 |
S1 |
p. S239-S244
6 p.
|
article
|
| 49 |
Radiotherapy versus radiotherapy enhanced by cisplatin in stage III non-small cell lung cancer
|
|
|
1994
|
10 |
S1 |
p. S337-
1 p.
|
article
|
| 50 |
Should current management of small cell lung cancer include prophylactic cranial irradiation?
|
Kristjansen, Paul E.G.
|
|
1994
|
10 |
S1 |
p. S319-S329
11 p.
|
article
|
| 51 |
Staging of lung cancer
|
|
|
1994
|
10 |
S1 |
p. S333-S334
2 p.
|
article
|
| 52 |
Surgical considerations after preoperative treatment
|
Ginsberg, Robert J.
|
|
1994
|
10 |
S1 |
p. S213-S217
5 p.
|
article
|
| 53 |
The response of non-small cell lung cancer to palliative radiotherapy is enhanced by the concurrent administration of 5-fluorouracil (5FU)
|
|
|
1994
|
10 |
S1 |
p. S334-S335
2 p.
|
article
|
| 54 |
Toxicity of combined radiation and chemotherapy in non-small cell lung cancer
|
Van Houtte, P.
|
|
1994
|
10 |
S1 |
p. S271-S280
10 p.
|
article
|
| 55 |
Toxicity of thoracic radiotherapy on pulmonary function in lung cancer
|
Choi, Noah C.
|
|
1994
|
10 |
S1 |
p. S219-S230
12 p.
|
article
|
| 56 |
Treatment evaluation
|
Hansen, H.
|
|
1994
|
10 |
S1 |
p. S7-S9
3 p.
|
article
|
| 57 |
Treatment evaluation of combined modality therapy: ‘What can we obtain today from Phase II trials?’
|
Thatcher, N.
|
|
1994
|
10 |
S1 |
p. S117-S133
17 p.
|
article
|
Journal description